p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs

Oncogene

Volumn 15, Issue 14, 1997, Pages 1727-1736

  Knippschild, U ^a   Milne, D M ^a   Campbell, L E ^a   DeMaggio, A J ^b   Christenson, E ^b   Hoekstra, M F ^b   Meek, D W ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

CK1 ; CK1 ; DNA damage; p53; Phosphorylation; Protein kinase

Indexed keywords

CAMPTOTHECIN; CASEIN KINASE I; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GLUTATHIONE TRANSFERASE; GREEN FLUORESCENT PROTEIN; GYRASE INHIBITOR; HYBRID PROTEIN; ISOENZYME; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN KINASE INHIBITOR; PROTEIN P53; SERINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME KINETICS; ENZYME PURIFICATION; GENE INDUCTION; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALIA; MURINAE;

EID: 0030670332     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201541     Document Type: Article

References (43)

1. Aloni GR, Schwartz D and Rotter V. (1995). EMBO J., 14, 1392-401.
2. Brockman JL, Gross SD, Sussman MR and Anderson RA. (1992). Proc. Natl. Acad. Sci. USA, 89, 9054-9058.
3. Cegielska A and Virshup DM. (1993). Mol. Cell. Biol., 13, 1202-1211.
4. Christenson E, DeMaggio AJ and Hoekstra MF. (1996). Rec. Results Cancer Res., 143, 263-274.
5. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid BJ. (1995). Science, 267, 1353-1356.
6. Dhillon N and Hoekstra MF. (1994). EMBO J., 13, 2777-2788.
7. Eliyahu D, Goldfinger N, Pinhasi-Kimhi O, Shaulsky G, Skurnik Y, Arai N, Rotter V and Oren M. (1988). Oncogene, 3, 313-321.
8. Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O and Oren M. (1989). Proc. Natl. Acad. Sci. USA, 86, 8763-8767.
9. Ferrell JE and Martin GS. (1991). Methods Enzymol., 200, 430-435.
10. Fiscella M, Ullrich SJ, Zambrano N, Shields MT, Lin D, Lees MS, Anderson CW, Mercer WE and Appella E. (1993). Oncogene, 8, 1519-1528.
11. Fish KJ, Cegielska A, Getman ME, Landes GM and Virshup DM. (1995). J. Biol. Chem., 270, 14875-14883.
12. Gottlieb TM and Oren M. (1996). Biochim. Biophys. Acta, 1287, 77-102.
13. Graessmann A and Graessmann M. (1983). Methods Enzymol., 101, 482-492.
14. Graves PR, Haas DW, Hagedorn CH, DePaoli-Roach AA and Roach PJ. (1993). J. Biol. Chem., 268, 6394-6401.
15. Hall PA, Meek D and Lane DP. (1996). J. Path., 180, 1-5.
16. Hoekstra MF, Liskay RM, Ou AC, DeMaggio AJ, Burbee DG and Heffron F. (1991). Science, 253, 1031-1034.
17. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
18. Jacks T and Weinberg RA. (1996). Nature, 381, 643-644.
19. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res, 51, 6304-6311.
20. Kastan MB, Zhan Q, el DW, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ. (1992). Cell, 71, 587-597.
21. Kinzler KW and Vogelstein B. (1996). Nature, 379, 19-20.
22. Knippschild U, Milne D, Campbell L and Meek D. (1996). Oncogene, 13, 1387-1393.
23. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
24. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
25. Lane DP. (1993). Nature, 362, 786-787.
26. Lees-Miller SP, Chen Y-R and Anderson CW. (1990). Mol. Cell. Biol., 10, 6472-6481.
27. Lohrum M and Scheidtmann KH. (1996). Oncogene, 13, 2527-2539.
28. Luo K, Hurley TR and Sefton BM. (1991). Methods Enzymol., 201, 149-152.
29. Mayr GA, Reed M, Wang P, Wang Y, Schwedes JF and Tegtmeyer P. (1995). Cancer Res., 55, 2410-2417.
30. Meek DW. (1994). Seminars in Cancer Biology, 5, 203-210.
31. Meek DW and Eckhart W. (1988). Mol. Cell. Biol., 8, 461-465.
32. Milne DM, Campbell DG, Caudwell FB and Meek DW. (1994). J. Biol. Chem., 269, 9253-9260.
33. Milne DM, Campbell L, Campbell DG and Meek DW. (1995). J. Biol. Chem., 270, 5511-5518.
34. Milne DM, Palmer RH, Campbell DG and Meek DW. (1992). Oncogene, 7, 1361-1369.
35. Milne DM, Palmer RH and Meek DW. (1992). Nucleic Acids Res., 20, 5565-5570.
36. Otto A and Deppert W. (1993). Oncogene, 8, 2591-2603.
37. Paules RS, Levedakou EN, Wilson SJ, Innes CL, Rhodes N, Tlsty TD, Galloway DA, Donehower LA, Tainsky MA and Kaufmann WK. (1995). Cancer Res., 55, 1763-1773.
38. Pintel D, Bouck N and Di Mayorca G. (1981). J. Virol., 38, 518-528.
39. Rowles J, Slaughter C, Moomaw C, Hsu J and Cobb MH. (1991). Proc. Natl. Acad. Sci. USA, 88, 9548-9552.
40. Sambrook J, Fritsch EF and Maniatis T. (eds.) (1989) Molecular Cloning: a Laboratory Manual. (2nd Edition). Cold Spring Harbor Press: New York.
41. Santos JA, Logarinho E, Tapia C, Allende CC, Allende JE and Sunkel CE. (1996). J. Cell Sci., 109, 1847-1856.
42. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B and Costa J. (1992). Proc. Natl. Acad. Sci. USA, 89, 4495-4499.
43. Yonish RE, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M. (1991). Nature, 352, 345-347.